MeSH tree: D23.529.374
A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to diagnose rare but aggressive forms of brain and eye cancer earlier and with fewer invasive tests.
May 22, 2026
0
6
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key finding from a University of Bristol-led pilot randomized controlled clinical trial, published in JAMA ...
May 20, 2026
0
26
Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous ...
May 20, 2026
0
10
What if the very structures we thought were destroying the brain are actually trying to save it? A new study reveals that protein clumps, long considered toxic markers of diseases like Huntington's, act as a vital "quarantine" ...
May 19, 2026
0
20
Barrier organs that form boundaries between the body and the outside environment, such as the lungs, skin, and intestines, face a difficult balancing act. They must respond quickly to threats such as infection, but they also ...
May 16, 2026
0
12
Mayo Clinic researchers have identified an immune-regulating molecule that may help explain why some patients with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, do not respond to commonly ...
May 13, 2026
0
38
Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy directed at killing the leukemia cells may also harm the body's ability to make new, healthy blood ...
May 12, 2026
0
15
A blood stem cell donation can save the lives of people with leukemia. To collect these cells from the bloodstream, donors are given medication that mobilizes blood stem cells from the bone marrow. A pilot study now suggests ...
May 11, 2026
0
1
Every year, about 3 to 5 million people in the EU and the U.S. suffer a traumatic brain injury (TBI). In most cases, it is a mild brain injury (mTBI) due to a closed head injury (CHI) caused by falls, traffic accidents, contact ...
May 10, 2026
0
5
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (CSU).
May 5, 2026
0
6
